Citizen Scientist Study Fuels Launch of First Series of Interactive U.S. County Maps of Ticks Carrying Diseases

Bay Area Lyme Free Tick Testing Program map of tick species in the US

Citizen Scientist Study Fuels Launch of First Series of Interactive U.S. County Maps of Ticks Carrying Diseases

– Study finds ticks carrying disease-causing bacteria in 116 counties where they have not been previously documented by CDC –

PORTOLA VALLEY, CA, October 20, 2021—Bay Area Lyme Foundation, a leading nonprofit funder of innovative Lyme disease research in the U.S., today announced the launch of interactive national tick maps of U.S. counties based on data published in mSphere, a multidisciplinary open-access journal of the American Society for Microbiology. The new data identify Ixodes ticks carrying disease-causing pathogens in 116 counties which were not previously identified by the Centers for Disease Control (CDC). 

“The area known to harbor disease-carrying ticks continues to expand, and we hope people across the US will use these interactive maps to learn more about the risks for their hometowns, their family’s residences and vacation spots,” said Linda Giampa, executive director, Bay Area Lyme Foundation. “The citizen scientists contributing to this study allowed the country’s collective tick knowledge to advance further than even the CDC could do at this time. Gaining the support of citizen scientists allowed us to collect from many counties across the country where ticks are not usually collected and tested, or they are not tested for these pathogens.”

Bay Area Lyme Foundation’s LymeAid® Brings Together an Enthusiastic Crowd to Celebrate Momentum in Infectious Disease Research

Bay Area Lyme Board of Directors at LymeAid 2021

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

 

Bay Area Lyme Foundation’s LymeAid® Brings Together an Enthusiastic Crowd to Celebrate Momentum in Infectious Disease Research

Dana Carvey and Pop Rocks featuring Mark McGrath energized the supportive audience of scientists, clinicians, patients and philanthropists gathered to advance promising Lyme research 

PORTOLA VALLEY, Calif., September 20, 2021—Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the United States, hosted its preeminent event, LymeAid, this weekend, its first in-person event since 2019. The event celebrated ongoing research of tick-borne disease, acknowledged important learnings from COVID-19 and pointed to the great need for the advancement of these efforts. Even with smaller numbers to allow for social distancing, LymeAid raised $650,000 of which 100 percent goes directly to fund scientific research, education and prevention programs for Lyme disease. Lyme disease is a potentially disabling infection diagnosed in nearly half a million Americans each year.

Emmy-award winning comedian Dana Carvey, was the Master of Ceremonies and received a standing ovation for his live performance, his first in 20 months. And, Pop Rocks featuring Mark McGrath delivered an outstanding show that got everyone dancing.

A leading U.S. expert on COVID-19 Charles Chiu, MD, PhD, of the University of California, San Francisco presented insights and research related to the similarities between COVID-19 and Lyme disease, including the difficulties in diagnosing each disease.

Herbal Medicines Demonstrate Potency Against Bartonella, a Disease-causing Pathogen, According to New Lab Study

Herbal Medicines Demonstrate Potency Against Bartonella

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

Herbal Medicines Demonstrate Potency Against Bartonella, a Disease-causing Pathogen, According to New Lab Study

Three of these herbal medicines also have high potency against Borrelia burgdorferi, the bacterium that causes Lyme disease, and Babesia duncani, according to previous lab studies also funded by Bay Area Lyme Foundation

PORTOLA VALLEY, CA, August 5, 2021—Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., today announced the publication of new data showing that herbal medicines have potent activity in test tubes compared to pharmaceuticals commonly-prescribed for the treatment of Bartonella henselae, a bacterium believed  to be carried by ticks and the cause of cat scratch fever. This is the first study to find antimicrobial activity of some of these herbal medicines. Published in the journal Infectious Microbes & Diseases, the laboratory study was funded in part by the Bay Area Lyme Foundation.

“With increasing rates of tick-borne diseases and a consistent concern about the overuse of antibiotics, this early research of herbals is extremely exciting,” said Linda Giampa, executive director, Bay Area Lyme Foundation. “We are hopeful that future pre-clinical and clinical studies will continue to show that herbals have the same effectiveness as this study and other recently-published studies.”

Bay Area Lyme Foundation Selects National Winners of the 2021 Emerging Leader Awards to Advance Research for the Diagnosis and Treatment of Lyme Disease

2021 Emerging Leader Awards

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

Bay Area Lyme Foundation Selects National Winners of the 2021 Emerging Leader Awards to Advance Research for the Diagnosis and Treatment of Lyme Disease

Brandon Jutras, PhD of Virginia Tech, Nitya Ramadoss, PhD of Stanford University and Michael P. Rout, PhD of The Rockefeller University are this year’s recipients

PORTOLA VALLEY, Calif., July 6th, 2021—Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., announces the recipients of the 2021 Emerging Leader Awards (ELA), which are designed to support promising scientists who represent the future of Lyme disease research leadership. Michael P. Rout, PhD of The Rockefeller University will receive $250,000 for his work with nanobodies to develop a sensitive point-of-care diagnostic. Brandon Jutras, PhD of Virginia Tech and Nitya Ramadoss, PhD of Stanford University will each receive $100,000 toward the development of a novel direct-detection diagnostic approach for Lyme disease and a novel therapeutic based on B-cell mapping, respectively. Lyme disease is a potentially disabling infection diagnosed in nearly half a million Americans each year.

“As there is not a diagnosis or treatment that works for all patients, there is a critical need to develop direct-detection diagnostics as well as treatments that can prevent the development of persistent Lyme disease, and we are excited to support these novel approaches that have shown success in other areas,” said Linda Giampa, executive director, Bay Area Lyme Foundation.

Two of the award winners will utilize biological samples from the Lyme Disease Biobank, a program of the Bay Area Lyme Foundation, to collect well-characterized human tissue, blood and urine specimens to accelerate research of Lyme disease and other tick-borne infections.

Ticks Carrying Disease Found to Be Abundant in Beach Areas, Similar to Woodlands, According to New Study

Ticks Carrying Disease Found to Be Abundant in Beach Areas

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

 

Ticks Carrying Disease Found to Be Abundant in Beach Areas, Similar to Woodlands, According to New Study

Study Funded by Bay Area Lyme Foundation Also Shows Ticks in Northern California Carry a Diversity of Disease-causing Bacteria at Higher Rates Than Previously Reported

Portola Valley, CA, April 23, 2021—Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, today announced results of a study demonstrating that adult Western black-legged ticks (Ixodes pacificus) carrying Borrelia burgdorferi, the bacterium that causes Lyme disease, were found in beach areas at equal rates to the woodland habitats in parts of northwestern California. Further, researchers, who were testing ticks for up to 5 species of tick-borne bacteria, found that the collective infection rate of all species was as high as 31% in at least one area, which offers a different perspective from previous studies that tested for a single species of bacteria in a specific area or areas. Conducted by researchers at Colorado State University, Northern Arizona State University and Translational Genomics Research Institute (TGen), and published in the June issue of the peer-reviewed journal Applied and Environmental Microbiology (AEM), the research points to the need for greater education for both the community at large and healthcare providers about the risks of tick-borne disease.

“The high rate of disease-carrying ticks in the coastal chaparral was really surprising to us. And when looking at all the tick-borne pathogens simultaneously, it makes you rethink the local disease risk,” said Lead Author Daniel Salkeld, PhD, Colorado State University. “Previously, we, along with other researchers, may have missed the big picture when we focused our attention on investigating the risk of one pathogen at a time. Now, we have a new imperative to look at the collective risk of all tick-borne pathogens in an area.”

Bay Area Lyme Foundation Announces Call for Entries for the 2021 Emerging Leader Awards

2021 Emerging Leader Awards

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

Bay Area Lyme Foundation Announces Call for Entries for the 2021 Emerging Leader Awards

Grant aims to inspire new research toward overcoming the challenges of Lyme disease

PORTOLA VALLEY, Calif., November 17, 2020—Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the US, is announcing a call for entries for their 2021 Emerging Leader Awards (ELA), which are designed to encourage scientists who embody the future of Lyme disease research leadership in the US. This year, two grants, $250,000, and $100,000 will be awarded. Recipients will be researchers from academia or the private sector in the US. who have not necessarily conducted previous research in tick-borne diseases. All applicants are encouraged to bring learnings from other therapeutic areas to their research projects. Their proposal must have a defined scientific approach and rationale that can advance diagnostics or treatments for Lyme disease. Applications will be accepted through February 15, 2021, at midnight pacific. The full criteria and application for this award can be found here.

“This year has given us all the opportunity to consider the great importance of medical research and the devastation that can arise when a pathogen is not well-understood by the medical and scientific community,” said Wendy Adams, research grant director, Bay Area Lyme Foundation. “We clearly need novel approaches to make Lyme disease easy to diagnose and simple to cure, and we hope these awards offer the support that innovative researchers require.”

Jacob Lemieux, MD, DPhil and Artem Rogovskyy, DVM, PhD Named Recipients of Bay Area Lyme Foundation’s 2020 Emerging Leader Award

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

Jacob Lemieux, MD, DPhil and Artem Rogovskyy, DVM, PhD Named Recipients of Bay Area Lyme Foundation’s 2020 Emerging Leader Award

Biobank Samples to Aid 2020 Emerging Leader Award Winners in Discovery of New Rapid and Sensitive Diagnostics for Lyme Disease Testing

PORTOLA VALLEY, Calif., August 11, 2020 — Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., announces the recipients of the 2020 Emerging Leader Awards, which are designed to support promising scientists who represent the future of Lyme disease-research leadership. Jacob Lemieux, MD, DPhil of Harvard and Massachusetts General Hospital, and Artem Rogovskyy, DVM, PhD of Texas A&M University will each receive $100,000 toward the development of novel direct-detection diagnostic approaches for Lyme disease. Both researchers will utilize biological samples from the Lyme Disease Biobank, a program of the Bay Area Lyme Foundation, working to accelerate research of Lyme disease and other tick-borne infections. Lyme disease is a potentially disabling infection impacting more than 400,000 Americans each year.

“The value of research proposed by our grant recipients is vital to our mission of making Lyme disease easy to diagnose and simple to cure.  In this year of COVID-19, we are pleased to have the opportunity to continue our grant program to fund the important work of these scientists addressing the most crucial requirement for Lyme disease – an accurate diagnostic test,” said Linda Giampa, executive director, Bay Area Lyme Foundation.

Lyme Disease Biobank Expands Into San Diego

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

Lyme Disease Biobank Expands Into San Diego

Legislative Commendations Support Importance of New Collection Site’s Efforts To Elevate Research

San Diego, CA, March 6, 2020—Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., announces the opening of the San Diego collection site of the Bay Area Lyme Foundation’s Lyme Disease Biobank, which is the first program to provide researchers with blood and urine samples from people with early Lyme disease from multiple endemic regions across the country. Congressman Scott Peters and Council member Chris Cate are scheduled to speak at the ribbon-cutting ceremony for the new collection site, and Council President Pro Tem Barbara Bry, Senator Toni Atkins, and Assembly member Todd Gloria will send representatives to issue commendations to support this event.

“Lyme disease is a growing problem in the County of San Diego, because many of our residents travel to or relocate from other more highly endemic areas and it is also possible to be infected locally,” said Sharon Wampler, PhD, who was instrumental in bringing Bay Area Lyme Foundation’s Lyme Disease Biobank to San Diego. “As a world-class hub for research and innovation, we can be part of the solution. This biobank is an important resource which will help researchers answer many current scientific questions about tick-borne diseases.”

New Study Shows Less Than One-Third of Lyme Disease Test Results are Accurate for Patients with Lyme Rash

Lyme Disease Biobank

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

New Study Shows Less Than One-Third of Lyme Disease Test Results are Accurate for Patients with Lyme Rash

Journal of Clinical Microbiology Publishes Lyme Disease Biobank Data Describing Samples Available for Research on Tick-Borne Infections

Portola Valley, Calif., February 26, 2020—Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., announces results published in the Journal of Clinical Microbiology, a journal of the American Society for Microbiology, that point to limitations of currently available diagnostic tests for early-stage Lyme disease and highlight the need for more research toward improved diagnostics and treatments. Among the findings, the Centers for Disease Control’s Standard Two-tier Testing Algorithm (STTTA) for Lyme disease failed to accurately diagnose 71% of blood samples from individuals presenting with a Lyme rash, also known as an erythema migrans, greater than 5 cm in endemic areas. These samples are part of the Lyme Disease Biobank (LDB), which was founded to catalyze new research in the understanding, diagnosis and treatment of Lyme disease and other tick-borne infections. Samples are available for research use through an application process to scientists who already work in tick-borne infections, as well as those new to the field.

Seven Herbal Medicines Are Capable of Killing Lyme Disease Bacteria, According to New Lab Study

FOR IMMEDIATE RELEASE

Media Contact:
Tara DiMilia, 908-947-0500, tara.dimilia@TMstrat.com

Seven Herbal Medicines Are Capable of Killing Lyme Disease Bacteria, According to New Lab Study

Research Supported by Bay Area Lyme Foundation Evaluates Anti-microbial Effects of 14 Natural Products Compared to Antibiotics Used to Treat Lyme Disease

Marin, CA, February 21, 2020—Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., today announced the publication of new data finding that seven herbal medicines are highly active in test tubes against B. burgdorferi, the bacteria that causes Lyme disease, compared to the control antibiotics, doxycycline and cefuroxime. Published in the journal Frontiers in Medicine, the laboratory study was funded by the Bay Area Lyme Foundation and supported in part by The Steven & Alexandra Cohen Foundation. The study was a collaboration between researchers at Johns Hopkins Bloomberg School of Public Health and colleagues at the California Center for Functional Medicine and FOCUS Health Group, Naturopathic.

“Since traditional antibiotic approaches fail to resolve symptoms in up to 25% of patients treated for Lyme disease and many suffer disabling effects of the disease, there is a need for novel treatment proven effective against B. burgdorferi,” said the paper’s co-author Sunjya K. Schweig, MD, CEO and co-director, California Center for Functional Medicine and Scientific Advisory Board Member, Bay Area Lyme Foundation. “Because patients are currently turning to herbal remedies to fill the treatment gaps left by antibiotics, this research is a critical step in helping clinicians, as well as patients, understand which ones may offer the most potential benefit.”